Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCORE trial
PACTR202007828853091Phase 1Not yet recruiting
- Sponsor
- Oxford Road Day Clinic
- Start
- Aug 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 1 trial of autologous adipose-derived mesenchymal stromal cells in ovarian hypofunction (POI), Diminished Ovarian Reserve (DOR) and female infertility (2 arms), sponsored by Oxford Road Day Clinic. Primary endpoints: Hormonal biomarkers indicating recovery of ovarian function, Resumption of menstruation and 1 more. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
ovarian hypofunction (POI)Diminished Ovarian Reserve (DOR)female infertility
Beyond the preview
Go deeper on PACTR202007828853091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202007828853091.